NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Leyden Labs

Leyden Labs

Private
LeidenHealthcare & Life Scienceshttps://leydenlabs.com/

Last Round

VC Round

Jun 25, 2026

Total Funding Raised

$349.97M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Leyden Labs is a biotechnology company that develops intranasal products aimed at liberating humanity from respiratory viruses by providing broad-spectrum protection against multiple viral strains simultaneously.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

intranasal sprayrespiratory virus protectionmucosal protectionnasal vaccinebiotechnologyviral transmission preventionbroadly neutralizing antibodiespandemic preparednessclinical-stage biotechdrug developmentnasal drug deliverymucosal immunologyflu preventioncoronavirus protection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leyden Labs Comparables

Compare Leyden Labs with similar companies based on industry and business-model similarity.

Leyden Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NorthLinks Bio
85%
Blue Lake Biotechnology, Inc.
83%
InvisiShield Technologies
82%

Leyden Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 25, 2026
VC RoundOct 2, 2025
DebtJun 3, 2025
VC RoundJan 9, 2025
Series BJan 25, 2022
Series A
Mar 25, 2021

Key People

Founding team and executive leadership

Koenraad Wiedhaup

Founder And CEO

Founding Team

Marieke van der Lans

CFO, Chief Business Functions Officer

Executive Team

Leyden Labs Investors

Notable investors and investment history

Leyden Labs investors
InvestorRounds
SoftBank Investment AdvisersSeries B, VC Round
European Innovation Council FundVC Round
GVVC Round, Series B, Series A
Invest-NLVC Round
F-Prime CapitalSeries A, Series B, VC Round
ClavystBioVC Round
SoftBank GroupSeries B, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2026

    $46M raised with Gates Foundation and others

  • Oct 2, 2025

    $35.26M round led by European Innovation Council and Invest-NL.

Leyden Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Leyden Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Leyden Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersLeiden
Employee Range83
Year Founded2020
Last FundingJun 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.